Carmen Valcarce

768 total citations
27 papers, 579 citations indexed

About

Carmen Valcarce is a scholar working on Clinical Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Carmen Valcarce has authored 27 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Biochemistry, 10 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Carmen Valcarce's work include Metabolism and Genetic Disorders (7 papers), ATP Synthase and ATPases Research (5 papers) and Alzheimer's disease research and treatments (5 papers). Carmen Valcarce is often cited by papers focused on Metabolism and Genetic Disorders (7 papers), ATP Synthase and ATPases Research (5 papers) and Alzheimer's disease research and treatments (5 papers). Carmen Valcarce collaborates with scholars based in Spain, United States and Sweden. Carmen Valcarce's co-authors include José M. Cuezva, Imogene Dunn, Johan Stenflo, Aaron H. Burstein, Jorgina Satrústegui, Marwan N. Sabbagh, L. Altstiel, Egon Persson, Ingemar Björk and John B. Buse and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Carmen Valcarce

27 papers receiving 561 citations

Peers

Carmen Valcarce

PHYSI

SURGE

EDM

Ksenija Fumić Croatia

Mohammad Keramatipour Iran

Janine Reunert Germany

Wangwei Cai China

Julie Lavie France

Marianne Grüneberg Germany

Anne‐Frédérique Dessein France

Hironori Tamei Japan

B. Obermaier–Kusser Germany

Diana L. Fitzpatrick United States

Ksenija Fumić Croatia

Carmen Valcarce

498 ×1.8

248 ×1.6

PHYSI

329 ×2.3

44 ×0.5

SURGE

32 ×0.4

EDM

Citations per year, relative to Carmen Valcarce Carmen Valcarce (= 1×) peers Ksenija Fumić

Countries citing papers authored by Carmen Valcarce

Since Specialization

Citations

This map shows the geographic impact of Carmen Valcarce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Valcarce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Valcarce more than expected).

Fields of papers citing papers by Carmen Valcarce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Valcarce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Valcarce. The network helps show where Carmen Valcarce may publish in the future.

Co-authorship network of co-authors of Carmen Valcarce

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Valcarce. A scholar is included among the top collaborators of Carmen Valcarce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Valcarce. Carmen Valcarce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klein, Klara R., Schafer Boeder, Imogene Dunn, et al.. (2022). Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes. Diabetes Obesity and Metabolism. 24(8). 1439–1447. 7 indexed citations

Burstein, Aaron H., et al.. (2020). Effects of azeliragon on ADAS‐cog and CDR domains and individual items in patients with mild Alzheimer's disease and type 2 diabetes (T2D). Alzheimer s & Dementia. 16(S9). 4 indexed citations

Vella, Adrian, et al.. (2019). Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator. Science Translational Medicine. 11(475). 49 indexed citations

Valcarce, Carmen, Imogene Dunn, & Jennifer L. Freeman. (2019). 1015-P: Effects of the Oral, Small Molecule GLP-1R Agonist TTP273 on Patients with Stage 2 Hypertension: Results from a Post Hoc Analysis of the Phase 2 Logra Study. Diabetes. 68(Supplement_1). 4 indexed citations

Burstein, Aaron H., et al.. (2018). Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 5(2). 149–154. 118 indexed citations

Kostura, Matthew J., Mark S. Kindy, Aaron H. Burstein, et al.. (2014). P3‐032: EFFICACY OF RAGE ANTAGONISTS IN MURINE MODEL OF ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_17). 3 indexed citations

Dutia, Roxanne, Matthew Modes, Robert Rothlein, et al.. (2013). Effects of AgRP Inhibition on Energy Balance and Metabolism in Rodent Models. PLoS ONE. 8(6). e65317–e65317. 23 indexed citations

Valcarce, Carmen, Ingemar Björk, & J Stenflo. (1999). The epidermal growth factor precursor. European Journal of Biochemistry. 260(1). 200–207. 11 indexed citations

Valcarce, Carmen, José M. Izquierdo, Margarita Chamorro, & José M. Cuezva. (1994). Mammalian adaptation to extrauterine environment: mitochondrial functional impairment caused by prematurity. Biochemical Journal. 303(3). 855–862. 23 indexed citations

10.

Valcarce, Carmen, A. Holmgren, & Johan Stenflo. (1994). Calcium-dependent interaction between gamma-carboxyglutamic acid-containing and N-terminal epidermal growth factor-like modules in factor X. Journal of Biological Chemistry. 269(42). 26011–26016. 17 indexed citations

11.

Valcarce, Carmen, et al.. (1993). [24] Isolation of intact modules from noncatalytic parts of vitamin K-dependent coagulation factors IX and X and protein C. Methods in enzymology on CD-ROM/Methods in enzymology. 222. 416–435. 7 indexed citations

12.

Valcarce, Carmen, et al.. (1993). Calcium affinity of the NH2-terminal epidermal growth factor-like module of factor X. Effect of the gamma-carboxyglutamic acid-containing module.. Journal of Biological Chemistry. 268(35). 26673–26678. 36 indexed citations

13.

Stenflo, Johan, Ann-Kristin Öhlin, Egon Persson, et al.. (1991). Epidermal Growth Factor‐like Domains in the Vitamin K‐Dependent Clotting Factors. Annals of the New York Academy of Sciences. 614(1). 11–29. 8 indexed citations

14.

Valcarce, Carmen, et al.. (1991). Interaction of adenine nucleotides with the adenine nucleotide translocase regulates the developmental changes in proton conductance of the inner mitochondrial membrane. FEBS Letters. 294(3). 225–228. 26 indexed citations

15.

Cuezva, José M., et al.. (1990). Immunological detection of the mitochondrial F₁‐ATPase α subunit in the matrix of rat liver peroxisomes. FEBS Letters. 270(1-2). 71–75. 12 indexed citations

16.

Valcarce, Carmen, Javier Vitórica, Jorgina Satrústegui, & José M. Cuezva. (1990). Rapid postnatal developmental changes in the passive proton permeability of the inner membrane in rat liver mitochondria.. PubMed. 108(4). 642–5. 20 indexed citations

17.

Valcarce, Carmen, et al.. (1988). Postnatal development of rat liver mitochondrial functions. The roles of protein synthesis and of adenine nucleotides.. Journal of Biological Chemistry. 263(16). 7767–7775. 104 indexed citations

18.

Valcarce, Carmen, et al.. (1985). Increased gluconeogenesis in the rat at term gestation. Life Sciences. 37(6). 553–560. 15 indexed citations

19.

Fernández‐Espejo, Emilio, et al.. (1983). Postnatal hypoglycaemia and gluconeogenesis in the newborn rat. Delayed onset of gluconeogenesis in prematurely delivered newborns. Biochemical Journal. 214(2). 525–532. 22 indexed citations

20.

Valcarce, Carmen, et al.. (1979). El laboratorio de la revolución: el Tabasco garridista. Dialnet (Universidad de la Rioja). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact